Acutus medical reports preliminary unaudited second quarter 2021 financial results

Carlsbad, calif., july 12, 2021 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited results for the second quarter of 2021.
AFIB Ratings Summary
AFIB Quant Ranking